Table of Contents
ISRN Gastroenterology
Volume 2012 (2012), Article ID 960867, 5 pages
Research Article

Evaluation of the Appropriate Age Range of Colorectal Cancer Screening Based on the Changing Epidemiology in the Past 20 Years in Taiwan

1Department of Family Medicine, Taiwan Landseed Hospital, Ping-Jen City, Taoyuan 32449, Taiwan
2Department of Health Care Management, Chang Gung University, Taoyuan 33302, Taiwan
3Department of Computer Science and Information Engineering, National Central University, Taoyuan 32001, Taiwan
4Division of Gastroenterology, Department of Internal Medicine, Shin Kong Wu Ho-Su Memorial Hospital, Taipei 11101, Taiwan
5Department of Information Management, Hsing Wu College, New Taipei City 24452, Taiwan
6Department of Surgery, Taiwan Landseed Hospital, Ping-Jen City, Taoyuan 32449, Taiwan

Received 13 July 2012; Accepted 31 July 2012

Academic Editors: A. Amedei and A. Weimann

Copyright © 2012 Huan-Cheng Chang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Introduction. According to the recommendation of the United States Preventative Services Task Force, most countries provide average-risk screening for colorectal cancers (CRCs) between the ages of 50 and 75 years. However, the age range of screening should be modified because of an increasing life span. Methods. Totally 124,314 CRC cases were registered in Taiwan Cancer Registry from 1988 to 2007. The 20-year study period was divided into four 5-year increments. We divided the patients into four age groups (under age 50, age 50–74, age 74–84, and over age 85) in each increment to determine whether there were changes in the age distribution. Results. In the subgroup of patients under age 50, the number of CRC cases increased, but they accounted for a decreasing proportion of the total CRCs. In the 50–74 age group, the proportion of CRC cases also dropped. In contrast, the proportion increased in the 75–84 age group. Therefore, 43.63% of CRC patients would not be delegated to screen in the period of 2003–2007 if the CRC screening were restricted in the 50–74 age group. Conclusions. CRC screening for healthy individuals aged over 75 years is necessary.